327 results on '"Cohen, Jordana"'
Search Results
2. The 10-Year Effects of Intensive Lifestyle Intervention on Kidney Outcomes
3. Lowering Nighttime Blood Pressure With Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Con Side of the Argument
4. Response to Lowering Nighttime Blood Pressure with Bedtime Dosing of Antihypertensive Medications: Controversies in Hypertension - Pro Side of the Argument.
5. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
6. Treating Home Versus Predialysis Blood Pressure Among In-Center Hemodialysis Patients: A Pilot Randomized Trial.
7. Abstract 16652: Cardiovascular Outcomes of Renin-Angiotensin System Inhibition Amongst Non-Proteinuric Chronic Kidney Disease Patients in the Chronic Renal Insufficiency Cohort
8. Abstract 13622: Association Between Self-Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
9. Abstract 12444: Pulse Pressure and Cardiovascular and Renal Outcomes by Age in the Chronic Renal Insufficiency Cohort
10. Emergency Department/Urgent Care as Usual Source of Care and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort Study
11. Prediction of Incident Heart Failure in CKD: The CRIC Study
12. Trends in Initial Antihypertensive Medication Prescribing Among >2.8 Million Veterans Newly Diagnosed With Hypertension, 2000 to 2019.
13. Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection Fraction.
14. WCN24-908 ARTERIAL STIFFNESS AND ATRIAL FIBRILLATION IN CHRONIC KIDNEY DISEASE: RESULTS FROM THE CHRONIC RENAL INSUFFICIENCY COHORT
15. Proteomic Associations of Adverse Outcomes in Human Heart Failure
16. ATEMPTing to navigate between “lower is better” and “less is more”
17. Orthostatic Hypertension and Hypotension and Outcomes in CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study
18. Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction
19. Abstract 12661: Prognostic Significance of Tubular Injury Biomarkers in Heart Failure With Preserved Ejection Fraction (HFpEF)
20. Abstract 11642: Biologic Associations of the Senescence-Associated Secretory Phenotype (SASP) in Heart Failure (HF): Insights From Plasma Proteomics
21. Abstract 11540: Dephospho-Uncarboxylated Matrix Gla-Protein and Adverse Outcomes in Heart Failure: A Mendelian Randomization Analysis
22. Abstract 11559: Prognostic Significance of Senescence-Associated Secretory Phenotype (SASP) Biomarkers in Heart Failure (HF)
23. Abstract 10273: Proteomic Analysis of Chronic Kidney Disease (CKD) in Heart Failure With Preserved Ejection Fraction (HFpEF)
24. Cardiac Biomarkers and Risk of Mortality in CKD (the CRIC Study)
25. Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
26. Association Between Self‐Reported Medication Adherence and Therapeutic Inertia in Hypertension: A Secondary Analysis of SPRINT (Systolic Blood Pressure Intervention Trial)
27. Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management
28. Leveraging marginal structural modeling with Cox regression to assess the survival benefit of accepting vs declining kidney allograft offers
29. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association
30. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
31. Abstract 092: All-cause And Cardiovascular Mortality In White Coat Hypertension: An Updated Systematic Review And Meta-analysis
32. Trends in Primary Aldosteronism Screening Among High-Risk Hypertensive Adults.
33. Adverse Health Outcomes Associated With Refractory and Treatment-Resistant Hypertension in the Chronic Renal Insufficiency Cohort
34. New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
35. Primary Aldosteronism in Chronic Kidney Disease: Blood Pressure Control and Kidney and Cardiovascular Outcomes After Surgical Versus Medical Management
36. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
37. Abstract 14337: Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and Hypertension
38. Abstract 13340: 10-Year Risk Prediction Equations for Heart Failure in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort Study
39. Clinical and Proteomic Correlates of Plasma ACE2 (Angiotensin-Converting Enzyme 2) in Human Heart Failure
40. Response by Cohen et al to Letter Regarding Article, “Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19”
41. History and Justification of a National Blood Pressure Measurement Validated Device Listing
42. Identifying Patients for Intensive Blood Pressure Treatment Based on Cognitive Benefit
43. Proteomic cardiovascular risk assessment in chronic kidney disease
44. PROTEOMIC CORRELATES OF PLASMA POTASSIUM (K+) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
45. URINARY PROTEINS LEVELS ASSOCIATED WITH OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
46. PROTEOMIC ASSOCIATIONS OF N-TERMINAL (NT)-PRO HORMONE BNP (NT-PROBNP) IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF)
47. EFFECT OF SPIRONOLACTONE ON THE PLASMA PROTEOME IN HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF): IMPACT OF BASELINE N-TERMINAL (NT)-PRO B-TYPE NATRIURETIC PEPTIDE (BNP) LEVELS
48. Prognostic utility of rhythmic components in 24-hour ambulatory blood pressure monitoring for the risk stratification of chronic kidney disease patients with cardiovascular co-morbidity
49. Socioeconomic characteristics of those with peripheral artery disease in the chronic renal insufficiency cohort
50. Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.